Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 29 2026

May 29, 2026 at 12:29 PM EDT · Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE · May 29, 2026 at 12:29 PM EDT · 21 pages · English

On 6ix: 6ix.com/news/press-release-may-29-2026-9

Release

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, we are enclosing herewith the Press Release and Management Discussion & Analysis of the Company for the Fourth Quarter ended March 31, 2026.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Press Release May 20 2026May 20
Press Release May 18 2026May 17
Press Release Apr 09 2026Apr 9
Press Release Apr 01 2026Apr 1
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative PortfolioApr 1

Later from Glenmark Pharmaceuticals

Press Release Jun 05 2026Jun 4
Glenmark Pharmaceuticals Limited Press Release Jun 11 2026Jun 11
Glenmark Pharmaceuticals Limited Press Release Jun 17 2026Jun 16
Glenmark Pharmaceuticals Limited Press Release Jul 02 2026Jul 1
Glenmark Pharmaceuticals Limited Press Release Jul 06 2026Jul 5

All Glenmark Pharmaceuticals news releases

Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.

Follow Glenmark Pharmaceuticals